Autres langues Mauna Kea Technologies

Actions

ALMKT

FR0010609263

Marché Fermé - Euronext Paris Autres places de cotation 17:35:12 24/04/2024			Varia. 5j.	Varia. 1 janv.
0,3795 ^EUR	+0,40 %		-3,68 %	-19,43 %

04/04	GENFIT : Accor, Kering, Sanofi... les valeurs à suivre aujourd'hui à Paris -	AO
03/04	GENFIT : Eurazeo, Fermentalg, Solutions 30... les valeurs à suivre demain à Paris -	AO

Autres langues

Débloquez toutes les actualités sur toutes les entreprises : Ne manquez plus une opportunité d'investissement rentable !

Inscription 100% Gratuite

Mauna Kea Technologies Executes Agreement to Restructure its Existing Loan Agreement with the European Investment Bank	17:47
Mauna Kea : premier centre italien pour Cellvizio	03/04
Bolsa de Madrid: Después de Semana Santa, algo va mal	03/04
Mauna Kea Technologies Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	02/04
Mauna Kea Technologies : Announces the Opening of the First Italian Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	02/04
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	27/03
Mauna Kea Technologies Partners with V7 to Develop Innovative AI Applications with Cellvizio	27/03
Mauna Kea : partenariat avec Metrodora Institute aux USA	06/03
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	06/03
Mauna Kea Technologies Partners with Metrodora to Create First U.S. Center of Excellence for the Use of Cellvizio® to Identify and Treat Food Intolerance in Adults	06/03
MAUNA KEA TECHNOLOGIES REPORTS FULL YEAR 2023 SALES OF EUR10.5M, UP +42% VS 2022	26/01
Mauna Kea : Johnson & Johnson Innovation sous les 20%	24/11
Mauna Kea Technologies to Receive EUR6 Million Investment from Telix Pharmaceuticals	13/11
Mauna Kea : le titre bondit, Telix prend 19% du capital	13/11
Telix Pharmaceuticals Limited and Mauna Kea Technologies SA to Expand Collaboration in Urologic Oncology Surgery	13/11
Mauna Kea Technologies SA announced that it expects to receive ?6 million in funding from Telix Pharmaceuticals Limited	13/11
Mauna Kea Technologies : Inside Information / Other news releases	02/11
Mauna Kea Technologies Announces First Patient Enrolled in the Pivotal CLEVER Clinical Trial in Peripheral Lung Cancer	02/11
Mauna Kea Technologies Reports Sales Results for the Third Quarter and Nine Months Ended September 30, 2023	19/10/23
Mauna Kea Technologies Announces the Publication of Positive Results of a Randomized Controlled Trial in the Field of Interstitial Lung Disease	18/10/23

Aucun résultat pour cette recherche

Toute l'actualité Reco analystes Faits marquants Insiders Transcripts Communiqués Publications officielles Autres langues Idées de trading Articles Zonebourse Analyses Zonebourse

Autres langues Mauna Kea Technologies

Actions

ALMKT

FR0010609263

Autres langues

Filtres